Skip to content

Replimune Group REPL Lease, Right-of-Use Asset

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept repl:LeaseRightOfUseAsset.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's lease, right-of-use asset.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's lease, right-of-use asset?
Replimune Group (REPL) reported lease, right-of-use asset of $36.49M in Q4 2025.
How has Replimune Group's lease, right-of-use asset changed year-over-year?
Replimune Group's lease, right-of-use asset decreased by 7.7% year-over-year, from $39.54M to $36.49M.
What is the long-term trend for Replimune Group's lease, right-of-use asset?
Over 4 years (2021 to 2025), Replimune Group's lease, right-of-use asset has grown at a -6.3% compound annual growth rate (CAGR), from $50.27M to $38.81M.